ENB Therapeutics
  • Home
  • About
  • Pipeline
  • News/Blog
  • Contact Us
Select Page

Life Sciences Summit 2016 invites ENB to be a pipeline cafe participant

Jan 9, 2016 | Uncategorized

November, 2015

The Life Sciences Summit is an early stage investor and business development conference that highlights innovation. The pipeline café features academic innovators who are hand selected to present their discoveries, which are available for partnering. ENB was invited this year to be a Pipeline Cafe participant.

Recent Posts

  • ENB Therapeutics Announces Poster Presentation at the 2022 Summit for Cancer Immunotherapy
  • ENB Therapeutics Announces Orphan Drug Designation Granted by FDA for ENB-003 for the Treatment of Pancreatic Cancer
  • ENB Therapeutics Demonstrated Early Efficacy in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab
  • Early efficacy signals in ovarian cancer patients in ongoing Ph1 trial: Poster reporting findings presented at SITC 2020 Annual Meeting
  • ENB Therapeutics Announces Successful Completion of the First Dosing Cohort in Phase 1 Clinical Trial of ENB-003 in Combination with Pembrolizumab

Archives

  • November 2022
  • May 2022
  • February 2021
  • November 2020
  • February 2019
  • September 2018
  • April 2016
  • January 2016
  • June 2015

Categories

  • Press Releases
  • Uncategorized

Explore

  • Home
  • About
  • Pipeline
  • News/Blog
  • Contact Us

Recent Posts

Click Here

ENB Therapeutics
Alexandria Center For Life Sciences,
Launch Labs
430 E 29th Street, 14th Floor
New York, NY 10016
(212) 792-2317
info@enbpharma.com

Designed by Elegant Themes | Powered by WordPress